These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24158852)

  • 21. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
    He M; Rutledge SL; Kelly DR; Palmer CA; Murdoch G; Majumder N; Nicholls RD; Pei Z; Watkins PA; Vockley J
    Am J Hum Genet; 2007 Jul; 81(1):87-103. PubMed ID: 17564966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.
    Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL
    Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
    Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
    J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.
    Primassin S; Tucci S; Spiekerkoetter U
    Mol Genet Metab; 2011 Dec; 104(4):546-51. PubMed ID: 21963783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
    Tucci S
    J Inherit Metab Dis; 2017 May; 40(3):317-323. PubMed ID: 28247148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of impairment of mitochondrial fatty acid beta-oxidation.
    Hasegawa T; Hori N; Du W
    Keio J Med; 2002 Jun; 51(2):100-6. PubMed ID: 12125906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the inborn errors of mitochondrial fatty acid beta-oxidation deficiency].
    Zhu JM; Yang Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):214-7. PubMed ID: 16617370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype.
    Roe DS; Vianey-Saban C; Sharma S; Zabot MT; Roe CR
    Clin Chim Acta; 2001 Oct; 312(1-2):55-67. PubMed ID: 11580910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders.
    Dessein AF; Fontaine M; Dobbelaere D; Mention-Mulliez K; Martin-Ponthieu A; Briand G; Vamecq J
    Clin Chim Acta; 2009 Aug; 406(1-2):23-6. PubMed ID: 19422814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
    Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G
    Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients with complex I deficiency.
    Leipnitz G; Mohsen AW; Karunanidhi A; Seminotti B; Roginskaya VY; Markantone DM; Grings M; Mihalik SJ; Wipf P; Van Houten B; Vockley J
    Sci Rep; 2018 Jan; 8(1):1165. PubMed ID: 29348607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolite accumulation in VLCAD deficiency markedly disrupts mitochondrial bioenergetics and Ca
    Cecatto C; Amaral AU; da Silva JC; Wajner A; Schimit MOV; da Silva LHR; Wajner SM; Zanatta Â; Castilho RF; Wajner M
    FEBS J; 2018 Apr; 285(8):1437-1455. PubMed ID: 29476646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase.
    Clark-Taylor T; Clark-Taylor BE
    Med Hypotheses; 2004; 62(6):970-5. PubMed ID: 15142659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial fatty acid biosynthesis and muscle fiber plasticity in very long-chain acyl-CoA dehydrogenase-deficient mice.
    Tucci S; Mingirulli N; Wehbe Z; Dumit VI; Kirschner J; Spiekerkoetter U
    FEBS Lett; 2018 Jan; 592(2):219-232. PubMed ID: 29237229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers.
    Seminotti B; Leipnitz G; Karunanidhi A; Kochersperger C; Roginskaya VY; Basu S; Wang Y; Wipf P; Van Houten B; Mohsen AW; Vockley J
    Hum Mol Genet; 2019 Mar; 28(6):928-941. PubMed ID: 30445591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
    Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Ijlst L; Vaz FM; van Vlies N; Overmars H; Duran M; Wijburg FA; Wanders RJ; Strauss AW
    Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of mitochondrial fatty acid oxidation defects.
    Duran M; Bruinvis L; Ketting D; Dorland L
    Padiatr Padol; 1993; 28(1):19-25. PubMed ID: 8446424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-chain acyl-CoA profiles in cultured fibroblasts from patients with defects in fatty acid oxidation.
    Tamvakopoulos CS; Willi S; Anderson VE; Hale DE
    Biochem Mol Med; 1995 Jun; 55(1):15-21. PubMed ID: 7551821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
    Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
    Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.